Status:

UNKNOWN

Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's Ataxia

Lead Sponsor:

Jose Luis Urcelay Segura

Conditions:

Amyotrophic Lateral Sclerosis

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this study is to obtain an early biomarker of amyotrophic lateral sclerosis and Friedreich's Ataxia which allows to diagnose the disease in an initial stage and to follow up the patient wit...

Detailed Description

All patients will be asked about their data and their general medical history, and will be underwent on one hand, a complete neurological examination including the degree of neurological impairment qu...

Eligibility Criteria

Inclusion

  • Older than 18 years.
  • Best corrected visual acuity more than 0.4 (20/50 Snellen = 0.4 logMAR = 65 ETDRS letters).
  • Refractive defect less than 5 diopters of spherical equivalent and / or cylinder less than 2 diopters.
  • Transparent optical media: Opacity of crystalline \<1 according to Lens Opacities Classification System (LOCS) III.
  • Open anterior chamber angle assessed by gonioscopy with Goldmann lens (grade\> III).
  • Availability and collaboration to carry out the tests of the exploratory protocol.
  • Acceptance of informed consent.

Exclusion

  • Previous intraocular surgeries of less than 6 months of evolution. Patients with refractive surgery using the LASIK or LASEK technique will not be excluded.
  • Physical or mental difficulties to perform reliable and reproducible perimeters.
  • Pathology and / or ocular malformations, angular or optic nerve anomalies.
  • Any retinopathy or maculopathy.
  • Intraocular pressure (IOP)\> 21 mmHg.
  • Signal-to-noise ratio in OCT less than 5/10.
  • Failure to meet any inclusion criteria.
  • Mental retardation or any other limitation in obtaining informed consent.

Key Trial Info

Start Date :

July 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2020

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT03285204

Start Date

July 1 2015

End Date

February 1 2020

Last Update

February 26 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pilar Rojas Lozano

Madrid, Spain, 28010